Structures by: Velmurugan D.
Total: 407
C22H16BrNO4S
C22H16BrNO4S
Acta Crystallographica Section C (1998) 54, 5 635-637
a=9.012(2)Å b=13.492(2)Å c=16.808(2)Å
α=90.00° β=95.9910(10)° γ=90.00°
N-Benzoyl-N'-methyl-N'-phenyl thiourea
C15H14N2OS
Acta Crystallographica Section C (1999) 55, 8 1318-1320
a=8.4551(2)Å b=8.9044(2)Å c=10.7293(3)Å
α=91.1420(10)° β=107.4370(10)° γ=113.0350(10)°
C30H26N2O6S
C30H26N2O6S
Acta Crystallographica Section C (1999) 55, 8 1315-1317
a=10.2215(2)Å b=20.8692(4)Å c=12.87000(10)Å
α=90.00° β=98.1300(10)° γ=90.00°
(2R,3aR,4S,6aR,7aR)-cis-4-Benzyl-2-(4-bromophenyl)-5-(4- methylphenylsulfonyl)perhydrothiazolidino[3,4-a]pyrrolo[4,5-c]pyrrole
C28H29BrN2O2S2
Acta Crystallographica Section E (2007) 63, 5 o2213-o2215
a=14.7207(8)Å b=9.1692(5)Å c=20.6819(11)Å
α=90.00° β=109.4610(10)° γ=90.00°
Diethyl {3-[β-(2,4-dichlorophenyl)vinyl]-N-phenylsulfonyl-indol-2-ylmethyl}phosphonate
C27H26Cl2NO5PS
Acta Crystallographica Section C (2002) 58, 8 o450-o454
a=16.608(2)Å b=8.3570(10)Å c=19.647(5)Å
α=90° β=93.300(10)° γ=90°
2-Nitroso-1,3-diphenyl-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine
C24H19N3O
Acta Crystallographica Section C (2003) 59, 3 o153-o155
a=9.713(6)Å b=19.265(8)Å c=10.450(2)Å
α=90° β=105.74(3)° γ=90°
4-[4-(4-Chlorobenzoyl)-2,3-diphenylisoxazolidin-5-yl]-1-(4-methoxyphenyl)- 3-phenylazetidin-2-one
C38H31ClN2O4
Acta Crystallographica Section E (2012) 68, 10 o2914
a=10.1221(10)Å b=17.4890(17)Å c=17.7421(18)Å
α=90.00° β=98.150(6)° γ=90.00°